MENU
PLX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

A.I. Advisor
published Earnings

PLX is expected to report earnings to fall 70.00% to 2 cents per share on May 09

Protalix BioTherapeutics PLX Stock Earnings Reports
Q1'25
Est.
$0.03
Q4'24
Est.
$0.10
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.04
The last earnings report on March 17 showed earnings per share of 10 cents, meeting the estimate of 10 cents. With 456.75K shares outstanding, the current market capitalization sits at 202.88M.
View a ticker or compare two or three
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com